Navigation Links
Watson Pharmaceuticals Reports Second Quarter 2008 Results


Additions to marketable securities

and long-term investments (3,733) (4,230)

Proceeds from sale of marketable

securities and investments 3,878 2,548

Other investing activities, net - (337)

Net cash used in investing activities (29,359) (37,852)

Cash Flows from Financing Activities:

Payments on term loan, current debt

and other long-term liabilities (95,000) (251,881)

Proceeds from issuance of short-term debt 17,003 -

Proceeds from stock plans 2,194 11,172

Other (109) -

Net cash used in financing activities (75,912) (240,709)

Net decrease in cash and cash equivalents 60,915 (79,319)

Cash and cash equivalents at beginning of

period 204,554 154,171

Cash and cash equivalents at end of period $265,469 $74,852

The following table presents a reconciliation of reported net income and diluted earnings per share to adjusted net income and diluted earnings per share for the three and six months ended June 30, 2008 and 2007:

Table 4

Watson Pharmaceuticals, Inc.

Reconciliation Table

(Unaudited; in thousands except per share amounts)

Three Months Ended Six Months Ended

June 30, June 30,

2008 2007 2008 2007

GAAP to adjusted net income


Reported GAAP net income $60,303

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Watson Receives FDA Approval for Generic Accuneb(R)
3. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
4. Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
5. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
6. Barr Subsidiary Sues Watson for SEASONIQUE(R) Patent Infringement
7. Watson Files FDA Application for Generic LYBREL(R)
8. FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceuticals TRELSTAR(R) DEPOT and TRELSTAR(R) LA
9. Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
10. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
11. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
Post Your Comments:
(Date:3/3/2015)... March 3, 2015 /CNW/- SQI Diagnostics Inc. (TSX:V: SQD), ... technologies and products for advanced microarray diagnostics, today ... CFE  to its Management team. In his capacity ... its transition from a development stage to a ... advance the Company,s capital market strategy and to ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Crown Bioscience, ... company, has launched a new Life Science division specializing ... preclinical research. , The first products released include ... controls, and soon to be released in vivo grade ... continue to expand their life science portfolio with additional ...
(Date:3/3/2015)... Milpitas, Calif. (PRWEB) March 03, 2015 ... risk management excellence were honored by the Global ... annual event which took place on Wednesday, February 25th, ... , The GSCRC was formed to bring together supply ... thought leaders to advance the professional discipline through opportunities ...
(Date:3/3/2015)... PARSIPPANY, N.J. , March 3, 2015  Thingee ... industry, will be delivering a presentation entitled, "Technology Adoption: ... Conference, Thriving through Innovations and Technology ,  in ... from March 11 to 13, 2015. Audiences looking to ... more effectively will want to be in the audience ...
Breaking Biology Technology:SQI Diagnostics Appoints Chief Financial Officer 2SQI Diagnostics Appoints Chief Financial Officer 3Crown Bioscience Launches Life Science Product Catalog 2Global Supply Chain Resiliency Council Names Award Winners 2Global Supply Chain Resiliency Council Names Award Winners 3Global Supply Chain Resiliency Council Names Award Winners 4Thingee to present at 11th Annual Synergistix Users Conference 2
... Spherix Incorporated,(Nasdaq: SPEX ) reported that ... Nasdaq advising the Company that, because of the ... enforcement of,the bid price and market value requirements ... period will be in effect from October 16,2008 ...
... Michigan,s stem,cell research initiative -- Proposal 2 -- ... reprehensible Tuskegee Experiments as a basis,for comparison to ... myths and,misinformation. Distortions about the nature and regulatory ... is important to set the facts straight., ...
... England, Oct. 23 BioWisdom Ltd (BioWisdom),the ... the,pharmaceutical industry, today announces the release of ... data are increasingly being used in competitive ... and business decisions.,OmniViz Visualization Software can turn ...
Cached Biology Technology:Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period 2Anti-Stem-Cell-Research Ad Ignores Facts 2Anti-Stem-Cell-Research Ad Ignores Facts 3
(Date:2/5/2015)... Calif. , Feb. 3, 2015 ... technology, demand from industries such as consumer electronics, ... market for surface mount technology (SMT) screen printers. ... to automatic control will push the adoption curve ... will remain steady as glue dispensers are indispensable ...
(Date:1/22/2015)... Jan. 13, 2015  Today, FreeWavz ( ), ... crowdfunding campaign on Fundable, . FreeWavz ... production capacity to meet customer demand. ... Invented by ...
(Date:1/22/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a ... the recent success of the Wocket™ smart wallet at CES 2015 in ... was named as one of the "11 Hot Products at CES" in ... At CES So Far" by and "The top 10 gadgets from ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3
... cow disease-testing program is wholly inadequate and the ... testing further undercuts the safety of American beef, ... meat from cattle infected with bovine spongiform encephalopathy, ... a fatal human brain-wasting disorder. More than 160 ...
... NH&MRC, industry and state governments released today by the ... up to 275 new victims each day throughout Australia. ... Lifestyle Study (AusDiab) were presented today to the Federal ... provide the first definitive, clear picture of the rising ...
... proliferation of a broad range of lethal malignant glioma ... in the May issue of Cancer Cell, shed light ... to play a role in cancer progression. This study ... must display a broad reactivity to effectively attenuate the ...
Cached Biology News:Federal testing for mad cow disease a failure, law review editor says 2Federal testing for mad cow disease a failure, law review editor says 3Federal testing for mad cow disease a failure, law review editor says 4Diabetes hits 275 Australians each day as pandemic spreads 2Diabetes hits 275 Australians each day as pandemic spreads 3Unique dual target specificity of kinase inhibitor key for success against cancer 2
... chromatographically purified from egg white. The extinction coefficient ... is in 10 mM phosphate-buffered saline, ... 0.05% sodium azide and 50% glycerol. Avidin (from ... is purified by molecular sieving and ...
Request Info...
Request Info...
... ml CELLection Dynabeads (4.5 m) coated with ... antigen EpCAM and DNase Releasing Buffer. ... epithelial tumour cells directly from blood, bone ... be enriched from bone marrow. Enriched cells ...
Biology Products: